company background image
QPT logo

Quest PharmaTech TSXV:QPT Stock Report

Last Price

CA$0.025

Market Cap

CA$4.2m

7D

0%

1Y

-64.3%

Updated

26 Mar, 2024

Data

Company Financials

QPT Stock Overview

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

QPT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Quest PharmaTech Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Quest PharmaTech
Historical stock prices
Current Share PriceCA$0.025
52 Week HighCA$0.10
52 Week LowCA$0.02
Beta0.29
1 Month Change0%
3 Month Change-50.00%
1 Year Change-64.29%
3 Year Change-82.14%
5 Year Change-82.76%
Change since IPO-97.22%

Recent News & Updates

Recent updates

Shareholder Returns

QPTCA BiotechsCA Market
7D0%-1.8%0.2%
1Y-64.3%-28.6%9.0%

Return vs Industry: QPT underperformed the Canadian Biotechs industry which returned -27.7% over the past year.

Return vs Market: QPT underperformed the Canadian Market which returned 9.3% over the past year.

Price Volatility

Is QPT's price volatile compared to industry and market?
QPT volatility
QPT Average Weekly Movementn/a
Biotechs Industry Average Movement13.5%
Market Average Movement8.6%
10% most volatile stocks in CA Market18.5%
10% least volatile stocks in CA Market3.1%

Stable Share Price: QPT's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine QPT's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aMadi Madiyalakanhttps://www.questpharmatech.com

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer.

Quest PharmaTech Inc. Fundamentals Summary

How do Quest PharmaTech's earnings and revenue compare to its market cap?
QPT fundamental statistics
Market capCA$4.23m
Earnings (TTM)-CA$22.26m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QPT income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$22.26m
Earnings-CA$22.26m

Last Reported Earnings

Oct 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.13
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio1.5%

How did QPT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.